-
Filippo Berio announces exclusive partnership with Alzheimer's Drug Discovery Foundation, supporting critical research and brain health
08 Apr 2024 17:27 GMT
… in academia and the biotech industry. The ADDF… #39;s PET scan (Amyvid®) and blood test (PrecivityAD®) … ;s drug discovery programs, biomarker programs and clinical trials in … exclusive-partnership-with-alzheimers-drug-discovery-foundation-supporting-critical …
-
Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Center for Brain Health Medicines Invite Proposals for 2024 ADDF-Harrington Scholar Award
02 Apr 2024 15:58 GMT
… academic investigators at accredited medical centers, research institutions, … in academia and the biotech industry. The ADDF… #39;s PET scan (Amyvid®) and blood test (PrecivityAD®) … ;s drug discovery programs, biomarker programs and clinical trials in …
-
Alzheimer's Drug Discovery Foundation (ADDF) Statement on FDA Decision to Convene Advisory Committee for Donanemab
09 Mar 2024 01:36 GMT
… benefit from treatment. A unique aspect of this trial was the … -clearing drugs with novel therapies in a precision medicine approach … research in academia and the biotech industry. The ADDF… Alzheimer's PET scan (Amyvid®) and blood test (PrecivityAD®) …
-
Combination Therapy and Precision Medicine Spotlighted as the Gold Standard for the Next Generation of Alzheimer's Treatments in the Journal of Prevention of Alzheimer's Disease (JPAD)
17 Jan 2024 04:00 GMT
… drug development. Biomarkers allow for more targeted clinical trial participant recruitment, improved treatment … Scientific Founder and Medical and Scientific Director … from the Clinical Trials on Alzheimer… in academia and the biotech industry. The ADDF…
-
Medicare Lifts Its National Coverage Restriction On Alzheimer’s Disease PET Diagnostics
01 Nov 2023 17:59 GMT
… florbetapir 18F—marketed as Amyvid—became the first diagnostic … adverse treatment effects.
But soon after their approval, Medicare … an authorized clinical trial—preferably a randomized … regarding prescription drugs, diagnostics and medical devices are …
-
Momentum in Alzheimer's Research Guided by the Biology of Aging to be Highlighted in Session Moderated by Alzheimer's Drug Discovery Foundation at 2023 Clinical Trials on Alzheimer's Disease Conference
18 Oct 2023 16:01 GMT
… Alzheimer's drugs in clinical trials are exploring novel targets … #39;s treatments is combination therapy and precision medicine, so we … research in academia and the biotech industry. The ADDF… 's PET scan (Amyvid®) and blood test (PrecivityAD®) …
-
CuraSen Therapeutics Announces Strategic Investment from the Alzheimer’s Drug Discovery Foundation to Advance CST-3056, an Alpha-1A Adrenoceptor Agonist, for the Treatment of Alzheimer’s Disease
09 Oct 2023 13:12 GMT
… critically needed neurodegenerative disease treatment options to the … combination therapy and precision medicine.”
CuraSen will commence … in academia and the biotech industry. The ADDF… s drug discovery programs, biomarker programs and clinical trials in …
-
Revolutionizing Alzheimer's Prevention and Treatment: The Alzheimer's Drug Discovery Foundation and the FINGERS Brain Health Institute Announce Precision Prevention Partnership
04 Oct 2023 15:15 GMT
…
Collaborating with major pharmaceutical companies specializing in Alzheimer … in academia and the biotech industry. The ADDF … global multidomain dementia prevention trials, share experiences and … -prevention-and-treatment-the-alzheimers-drug-discovery-foundation …
-
BrainScope Receives Investment from the Alzheimer’s Drug Discovery Foundation for Alzheimer's Prediction Biomarker
19 Sep 2023 19:24 GMT
… for Alzheimer’s disease treatments is expected to rise … CEO and Chairman of Corvus Pharmaceuticals, a publicly traded clinical- … research in academia and the biotech industry. The ADDF… ;s drug discovery programs, biomarker programs and clinical trials in 19 …
-
BrainScope Receives Investment from the Alzheimer’s Drug Discovery Foundation for Alzheimer's Prediction Biomarker
19 Sep 2023 20:14 GMT
… for Alzheimer’s disease treatments is expected to rise … CEO and Chairman of Corvus Pharmaceuticals, a publicly traded clinical- … research in academia and the biotech industry. The ADDF… ;s drug discovery programs, biomarker programs and clinical trials in 19 …